These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38898525)

  • 1. Diabetic foot disease carries an intrinsic high risk of mortality and other severe outcomes in type 2 diabetes: a propensity score-matched retrospective population-based study.
    Vlacho B; Bundó M; Llussà J; Real J; Mata-Cases M; Cos X; Tundidor D; Zaccardi F; Khunti K; Jude EB; Franch-Nadal J; Mauricio D
    Cardiovasc Diabetol; 2024 Jun; 23(1):209. PubMed ID: 38898525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender Differences in the Risk of Adverse Outcomes After Incident Diabetic Foot Hospitalization: A Population Cohort Study.
    Seghieri G; Policardo L; Gualdani E; Francesconi P
    Curr Diabetes Rev; 2022; 18(6):e270821195904. PubMed ID: 34455962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of renal events in people with diabetic foot disease: A longitudinal observational study.
    Alkhami F; Rubin S; Borderie G; Foussard N; Larroumet A; Blanco L; Barbet-Massin MA; Domenge F; Mohammedi K; Rigalleau V
    Diabetes Metab; 2024 Jul; 50(4):101536. PubMed ID: 38701944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes-related foot disease in Australia: a systematic review of the prevalence and incidence of risk factors, disease and amputation in Australian populations.
    Zhang Y; van Netten JJ; Baba M; Cheng Q; Pacella R; McPhail SM; Cramb S; Lazzarini PA
    J Foot Ankle Res; 2021 Jan; 14(1):8. PubMed ID: 33468226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study.
    Fung CSC; Wan EYF; Chan AKC; Lam CLK
    BMC Cardiovasc Disord; 2017 Jun; 17(1):166. PubMed ID: 28645252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic foot disease and the risk of major clinical outcomes.
    Fang M; Hu J; Jeon Y; Matsushita K; Selvin E; Hicks CW
    Diabetes Res Clin Pract; 2023 Aug; 202():110778. PubMed ID: 37321302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study.
    Wang Z; Hazlehurst J; Subramanian A; Tahrani AA; Hanif W; Thomas N; Singh P; Wang J; Sainsbury C; Nirantharakumar K; Crowe FL
    Front Endocrinol (Lausanne); 2022; 13():888924. PubMed ID: 35898465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study (Evidence for Cardiovascular Outcomes With Sodium Glucose Cotransporter 2 Inhibitors in the Real World).
    Udell JA; Yuan Z; Rush T; Sicignano NM; Galitz M; Rosenthal N
    Circulation; 2018 Apr; 137(14):1450-1459. PubMed ID: 29133607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century.
    Lazzarini PA; Cramb SM; Golledge J; Morton JI; Magliano DJ; Van Netten JJ
    Diabetologia; 2023 Feb; 66(2):267-287. PubMed ID: 36512083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors of lower extremity amputations in people with type 2 diabetes in Taiwan, 2001-2010.
    Lai YJ; Hu HY; Lin CH; Lee ST; Kuo SC; Chou P
    J Diabetes; 2015 Mar; 7(2):260-7. PubMed ID: 24823436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors of diabetic foot disease among the people with type 2 diabetes using real-world practice data from Catalonia during 2018.
    Bundó M; Vlacho B; Llussà J; Puig-Treserra R; Mata-Cases M; Cos X; Jude EB; Franch-Nadal J; Mauricio D
    Front Endocrinol (Lausanne); 2022; 13():1024904. PubMed ID: 36353236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First cardiovascular event in patients with type 2 diabetes mellitus of a cardiovascular risk management program of a poor Colombian population: a cohort study.
    Miranda-Machado P; Salcedo-Mejía F; Wilches JP; Fernandez-Mercado J; De la Hoz-Restrepo F; Alvis-Guzmán N
    BMC Cardiovasc Disord; 2019 Jan; 19(1):8. PubMed ID: 30621603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term contemporary outcomes for staged versus primary lower limb amputation in diabetic foot disease.
    Cheun TJ; Jayakumar L; Sideman MJ; Ferrer L; Mitromaras C; Miserlis D; Davies MG
    J Vasc Surg; 2020 Aug; 72(2):658-666.e2. PubMed ID: 31901363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study.
    Yun JS; Park YM; Han K; Cha SA; Ahn YB; Ko SH
    Cardiovasc Diabetol; 2019 Aug; 18(1):103. PubMed ID: 31412855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes.
    Anyanwagu U; Mamza J; Mehta R; Donnelly R; Idris I
    Heart; 2016 Oct; 102(19):1581-7. PubMed ID: 27217068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia is independently associated with diabetic foot disease.
    Cheng Q; Hu J; Yang P; Cao X; Deng X; Yang Q; Liu Z; Yang S; Goswami R; Wang Y; Luo T; Liao K; Li Q
    Sci Rep; 2017 Aug; 7(1):8372. PubMed ID: 28827604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual Direct Medical Costs of Diabetic Foot Disease in Brazil: A Cost of Illness Study.
    Toscano CM; Sugita TH; Rosa MQM; Pedrosa HC; Rosa RDS; Bahia LR
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29316689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent association of history of diabetic foot with all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.
    Vitale M; Orsi E; Solini A; Garofolo M; Resi V; Bonora E; Fondelli C; Trevisan R; Vedovato M; Penno G; Pugliese G
    Cardiovasc Diabetol; 2024 Jan; 23(1):34. PubMed ID: 38218843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social Deprivation and Incident Diabetes-Related Foot Disease in Patients With Type 2 Diabetes: A Population-Based Cohort Study.
    Riley J; Antza C; Kempegowda P; Subramanian A; Chandan JS; Gokhale K; Thomas N; Sainsbury C; Tahrani AA; Nirantharakumar K
    Diabetes Care; 2021 Mar; 44(3):731-739. PubMed ID: 33483358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adding GLP-1RA on mortality, cardiovascular events, and metabolic outcomes among insulin-treated patients with type 2 diabetes: A large retrospective UK cohort study.
    Anyanwagu U; Mamza J; Donnelly R; Idris I
    Am Heart J; 2018 Feb; 196():18-27. PubMed ID: 29421011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.